World's Best Scientists 2026 revealed!
Acta Pharmacologica Sinica
H-index 47

Acta Pharmacologica Sinica

1671-4083

Published by: Springer

https://www.nature.com/aps/

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Chemistry 320 69 109 24
Medicine 753 44 70 28

Additional Metrics

Number of Best Scientists*: 298
Documents by Best Scientists*: 400
Top 100 Ranked Scientists*: 7
SCIMAGO H-index: 125
SCIMAGO SJR: 2.297
Impact Factor: 8.4

Overview

Top Research Topics at Acta Pharmacologica Sinica?

Acta Pharmacologica Sinica mainly tackles studies in Internal medicine, Endocrinology, Pharmacology, Molecular biology and Biochemistry. The research on Internal medicine tackled can also make contributions to studies in the areas of Anesthesia and Cardiology. The majority of Endocrinology studies are focused on the issues of Contraction (grammar).

In addition to Pharmacology research, it aims to explore topics under Immunology and In vivo. Molecular biology research presented in the journal encompasses a variety of subjects, including Apoptosis, In vitro, Cell culture and Cell growth. The concepts on Apoptosis presented in it can also apply to other research fields, including Cancer research and Cell biology.

  • Internal medicine (34.11%)
  • Endocrinology (30.13%)
  • Pharmacology (25.04%)

What are the most cited papers published in the journal?

  • Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. (627 citations)
  • Mesenchymal stem cells: a new trend for cell therapy. (582 citations)
  • Morinda citrifolia (Noni): a literature review and recent advances in Noni research. (471 citations)

Research areas of the most cited articles at Acta Pharmacologica Sinica:

The main points discussed in the published papers deal with Pharmacology, Internal medicine, Endocrinology, Molecular biology and Apoptosis. The most cited publications with studies in Pharmacology featured incorporate elements of Anesthesia, Biochemistry, In vivo and Traditional medicine. In addition to Apoptosis research, the most cited papers aim to explore topics under Immunology, Cancer research, Cell growth and Cell biology.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Gene
  • Enzyme

The previous edition focused in particular on these issues:

The main points discussed in Acta Pharmacologica Sinica deals with Pharmacology, Cancer research, Internal medicine, Apoptosis and Cell biology. While work presented in Acta Pharmacologica Sinica provided substantial information on Pharmacology, it also covered topics in Inflammation, Proinflammatory cytokine, Oxidative stress and In vivo. The work on Cancer research tackled in Acta Pharmacologica Sinica brings together disciplines like Cell culture, Cancer, Breast cancer, Cell growth and Downregulation and upregulation.

It focuses on Internal medicine research which is adjacent to topics in Endocrinology. The journal investigates Apoptosis research which frequently intersects with Signal transduction. The studies in Cell biology featured incorporate elements of Autophagy and Cancer cell.

The most cited articles from the last journal are:

  • Small molecule inhibitors targeting the PD-1/PD-L1 signaling pathway. (38 citations)
  • Matrine attenuates pathological cardiac fibrosis via RPS5/p38 in mice. (21 citations)
  • Identification of SARS-CoV-2 entry inhibitors among already approved drugs. (19 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Acta Pharmacologica Sinica (based on the number of publications) are:

  • Hualiang Jiang (51 papers) published 5 papers at the last edition, 4 more than at the previous edition,
  • Zheng-Hong Qin (47 papers) published 3 papers at the last edition the same number as at the previous edition,
  • Jian Ding (40 papers) published 4 papers at the last edition the same number as at the previous edition,
  • Ding-Feng Su (40 papers) published 1 paper at the last edition,
  • Kaixian Chen (38 papers) published 3 papers at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Acta Pharmacologica Sinica (based on the number of publications) are:

  • Chinese Academy of Sciences (829 papers) published 62 papers at the last edition, 23 more than at the previous edition,
  • Peking Union Medical College (276 papers) published 34 papers at the last edition, 23 more than at the previous edition,
  • Peking University (249 papers) published 9 papers at the last edition, 3 less than at the previous edition,
  • Fudan University (233 papers) published 32 papers at the last edition, 19 more than at the previous edition,
  • China Pharmaceutical University (212 papers) published 22 papers at the last edition, 5 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 1.79% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 56.84% were posted by at least one author from the top 10 institutions publishing in the journal. Another 10.94% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 17.33% of all publications and 14.89% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients.

    Hai xia Su;Sheng Yao;Wen feng Zhao;Min jun Li

    (2020)
    421 Citations
  • Growth factors-based therapeutic strategies and their underlying signaling mechanisms for peripheral nerve regeneration.

    Rui Li;Duo-hui Li;Hong-yu Zhang;Jian Wang

    (2020)
    152 Citations
  • Deletion of TLR4 attenuates lipopolysaccharide-induced acute liver injury by inhibiting inflammation and apoptosis

    Sai-Nan Chen;Ying Tan;Xiao-Chan Xiao;Qian Li

    (2021)
    113 Citations
  • Mitochondrial Ca2+ regulation in the etiology of heart failure: physiological and pathophysiological implications.

    Hai-xia Xu;Su-mei Cui;Ying-mei Zhang;Jun Ren;Jun Ren

    (2020)
    75 Citations
  • Mitochondrial aldehyde dehydrogenase (ALDH2) rescues cardiac contractile dysfunction in an APP/PS1 murine model of Alzheimer's disease via inhibition of ACSL4-dependent ferroptosis.

    Zhi-Yun Zhu;Yan-Dong Liu;Yan Gong;Wei Jin

    (2021)
    75 Citations
  • New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer’s disease

    (2020)
    71 Citations
  • Kanglexin, a novel anthraquinone compound, protects against myocardial ischemic injury in mice by suppressing NLRP3 and pyroptosis.

    Yu Bian;Xin Li;Ping Pang;Xue-ling Hu

    (2020)
    68 Citations
  • Zinc as a countermeasure for cadmium toxicity

    Hai-tao Yu;Hai-tao Yu;Juan Zhen;Juan Zhen;Ji-yan Leng;Lu Cai

    (2021)
    68 Citations
  • Rebalancing of the gut flora and microbial metabolism is responsible for the anti-arthritis effect of kaempferol.

    Li-xiang Aa;Fei Fei;Qi Qi;Run-bin Sun

    (2020)
    64 Citations

Related Online Degrees & Career Pathways

For those interested in medicine but seeking flexible or alternative career paths, online degrees offer a variety of opportunities. Advanced practice nurses, for example, can enhance their credentials through programs like the online DNP, which provide convenience without compromising the quality of education.

Medical coding is another essential healthcare field that supports the medical system. Obtaining a medical coder certification online can be an affordable and accessible way to enter the healthcare industry with strong job prospects.

For aspiring nurses, exploring nursing programs with high acceptance rates can simplify the admissions process and help start a nursing career sooner. These programs often balance accessibility with comprehensive training.

Healthcare administration is another promising pathway. Graduates can pursue leadership roles by enrolling in online health administration programs, which focus on the business side of healthcare to improve organizational efficiency and patient care.

Best Scientists Contributing to This Journal

Recently Published Articles